Patients who develop myocarditis within the first month of receiving immune checkpoint inhibitor therapy are more likely to have MC fatality.

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...

A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity. A novel method of treating immune checkpoint inhibitor (ICI)-associated ...

Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...

Immunotherapy can activate autoreactive T cells, causing myocarditis in about 1% of patients, with high mortality rates under standard corticosteroid treatment. A study compared standard high-dose ...

Myocarditis is recognized as a rare but serious adverse reaction to messenger RNA (mRNA) vaccination against COVID-19.

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of infectious ...

Please provide your email address to receive an email when new articles are posted on . Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits ...

Brazilian model Maiara Cristina de Lima Fiel died at the age of 31. She was to participate in a beauty pageant in the ...

People may use the term “viral heart disease” to describe viral myocarditis. This refers to when a viral infection causes inflammation of heart muscle tissue. Inflammation is the body’s natural ...

Early myocarditis onset may predict treatment-related fatality in patients receiving immune checkpoint inhibitor therapy.